Navigation Links
InVitria Announces Launch of Recombinant Albumin for Diagnostics
Date:4/17/2009

Fort Collins, CO, April 17, 2009 / b3c newswire / - Addressing significant product safety and consistency issues in the human diagnostics market, InVitria has announced the commercial launch of two protease-free recombinant albumin products. InVitria’s Recombinant Albumin-DX and Recombinant Albumin-DX (Lipid-Free) perform better in diagnostics applications than both bovine serum albumin (BSA) and plasma-derived human serum albumin (pHSA). 
  • The advantages of Recombinant Albumin-DX include:
  • Reduce non-specific binding and improve specificity;
  • Improved consistency due to recombinant manufacturing;
  • Improved stabilization of sensitive proteins and biomarkers; and
  • Reduce occupational safety risk and regulatory burden of handling human or animal blood products.
Customer testing has shown that Recombinant Albumin-DX (Lipid-Free) increased biomarker activity to levels twice as high as the current commercial alternative. In addition, stability over time was significantly improved with Recombinant Albumin-DX (Lipid-Free). Tests have also shown the bioequivalence of the Recombinant Albumin-DX to native human serum albumin (HSA).  
 
“InVitria is committed to developing high performance, regulatory friendly products for the diagnostics market and our Recombinant Albumin-DX and DX Lipid-Free products deliver on this promise,” said the company’s President and CEO Scott Deeter. “Recombinant Album-DX and DX Lipid-Free provide the specificity, stability and consistency that diagnostic customers seek.”
 
To receive a Recombinant Albumin-DX or DX Lipid-Free product materials packet, please contact InVitria’s customer service specialists at 1-800-916-8311 or by e-mail at info@InVitria.com.
ws" timex="4/17/2009 5:26:57 AM" dirsub="(bsp; About InVitria InVitria develops ...)" id="8019" index="biology" dir="InVitria Announces Launch of Recombinant Albumin for Diagnostics" dir2="InVitria Announces Launch of Recombinant Albumin for D..." keywords1=",biological,biology news articles,biology news today,latest biology news,current biology news,biology newsletters" keywords="InVitria,Announces,Launch,of,Recombinant,Albumin,for,Diagnostics" description="bsp; About InVitria InVitria develops manufactures and markets a portfolio of cell culture and diagnostic reagents. These products are used in cell culture biopharmaceutical formulation stem cell & regenerative medicine medical devices and diagnostics.   Learn more about InVitria’s products at a target _blank href http://www.in" url=u&"/biology-news-1/InVitria-Announces-Launch-of-Recombinant-Albumin-for-Diagnostics-8019-2/" title="InVitria%20Announces%20Launch%20of%20Recombinant%20Albumin%20for%20Diagnostics" %> InVitria Announces Launch of Recombinant Albumin for D... (Fort Collins CO April 17 2009 / b3c news...)
InVitria Announces Launch of Recombinant Albumin for Diagnostics
Date:4/17/2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/21/2016)... WAKEFIELD, Massachusetts , March 22, 2016 ... and facial recognition with passcodes for superior security ... MESG ), a leading provider of secure digital communications ... pilot their biometric technology and offer enterprise customers, particularly ... provide secure facial recognition and voice authentication within a ...
(Date:3/14/2016)... -- NXTD ) ("NXT-ID" or the "Company"), a ... airing of a new series of commercials on Time Warner ... st .  The commercials will air on Bloomberg TV, Fox ... Street show. --> NXTD ) ("NXT-ID" or the ... announces the airing of a new series of commercials on ...
Breaking Biology News(10 mins):
(Date:5/20/2016)... ... 2016 , ... The leading Regenerative Veterinary Medicine Company, VetStem Biopharma ., ... over 100 of their own patients with the VetStem Cell Therapy. Each of these ... for their patients. , The veterinarians are Dr Ross Rich former owner of ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers apoptosis, ... new way to treat the disease. Surviving Mesothelioma has just posted an article on ... several Korean institutions based their mesothelioma study on the fact the Manumycin A, a ...
(Date:5/19/2016)... ... May 19, 2016 , ... Anton Paar USA, located ... foot office building is complete. The new structure adds a third office building to ... Paar USA purchased 2.4 acres of land, along with office space adjacent to ...
(Date:5/19/2016)... YORK , May 19, 2016 ... space will fully recover given the relentless pressures in ... for sure in the investors circle though - numerous ... due-diligence. Ahead of today,s session, ActiveWallSt.com,s presents four names ... PTLA ), Vitae Pharmaceuticals Inc. (NASDAQ: VTAE ...
Breaking Biology Technology: